Phenanthridine

Phenanthridine

SCHEMBL28057333

O=C1NCc2ccccc21.c1ccc2c(c1)cnc1ccccc12

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.58
CA9 Q16790 1/20 0.58
KDM4E B2RXH2 1/20 0.56
GPR3 P46089 1/20 0.56
PARP1 P09874 4/20 0.48
PARP10 Q53GL7 2/20 0.41
PARP11 Q9NR21 2/20 0.41
PDPK1 O15530 1/20 0.41
TYRO3 Q06418 1/20 0.39
NTRK2 Q16620 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
AURKA O14965 1/20 0.39
KDR P35968 1/20 0.39
CYP1A2 P05177 1/20 0.38
TDP2 O95551 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
MKNK2 Q9HBH9 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31565696 0.77 CA12 (0.54) CA12CA9KDM4EPARP1PARP10
SCHEMBL29355184 0.76 CA12 (1.00) CA12CA9PARP1PARP10PARP11
SCHEMBL14896 0.76 CA12 (1.00) CA12CA9PARP1PARP10PARP11
SCHEMBL4818277 0.76 CA12 (1.00) CA12CA9PARP1PARP10PARP11
SCHEMBL27638376 0.76 CA12 (0.70) CA12CA9KDM4EPARP1PARP10
SCHEMBL8213864 0.75 CA12 (0.95) CA12CA9PARP1PARP10PARP11
Water SCHEMBL19462837 0.75 CA12 (0.95) CA12CA9PARP1PARP10PARP11
Hydrochloric Acid SCHEMBL5046932 0.75 CA12 (0.95) CA12CA9PARP1PARP10PARP11
SCHEMBL11354047 0.75 CA12 (0.95) CA12CA9PARP1PARP10PARP11
Water SCHEMBL19462703 0.75 CA12 (0.95) CA12CA9PARP1PARP10PARP11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105764501-A Compositions for improving the therapeutic benefit of bisantrene 现代化制药公司 2016-07-13 CN disclosed
CN-105764502-A Combination methods for improving the therapeutic benefit of bisantrene and analogs and derivatives thereof 现代化制药公司 2016-07-13 CN disclosed